SKping cell cycle regulation: role of ubiquitin ligase SKP2 in hematological malignancies
SKP2 (S-phase kinase-associated protein 2) is a member of the F-box family of substrate-recognition subunits in the SCF ubiquitin-protein ligase complexes. It is associated with ubiquitin-mediated degradation in the mammalian cell cycle components and other target proteins involved in cell cycle pro...
Main Authors: | Jonahunnatha Nesson George William, Ruby Dhar, Rohit Gundamaraju, Om Saswat Sahoo, Karthikeyan Pethusamy, A. F. P. Allwin Mabes Raj, Subbiah Ramasamy, Mohammed S. Alqahtani, Mohamed Abbas, Subhradip Karmakar |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1288501/full |
Similar Items
-
Emerging Roles of SKP2 in Cancer Drug Resistance
by: Ting Wu, et al.
Published: (2021-05-01) -
The Impact of SKP2 Gene Expression in Chronic Myeloid Leukemia
by: Hossam Hodeib, et al.
Published: (2022-05-01) -
Silybin has therapeutic efficacy against non-small cell lung cancer through targeting of Skp2
by: Shi-Bing Zhang, et al.
Published: (2022-08-01) -
Downregulation of SHIP2 by Hepatitis B Virus X Promotes the Metastasis and Chemoresistance of Hepatocellular Carcinoma through SKP2
by: Kuo-Jung Su, et al.
Published: (2019-07-01) -
Anti-tumor effects of Skp2 inhibitor AAA-237 on NSCLC by arresting cell cycle at G0/G1 phase and inducing senescence
by: Jinyi Liu, et al.
Published: (2022-07-01)